期刊文献+

肾透明细胞癌中AnnexinⅡ的表达及其临床意义 被引量:7

The expression and clinical significance of Annexin Ⅱ in clear-cell renal cell carcinoma
下载PDF
导出
摘要 目的:探讨AnnexinⅡ在人肾透明细胞癌和癌旁组织样本中的表达情况及其临床意义。方法:采用Western blot方法检测29例新鲜肾透明细胞癌及相应癌旁组织中AnnexinⅡ蛋白的表达;采用免疫组织化学方法检测120例肾透明细胞癌及相应癌旁组织中AnnexinⅡ的表达情况,并将结果与患者的临床病理参数及预后进行相关性分析。结果:AnnexinⅡ在肾透明细胞癌及相应癌旁组织中均有表达,前者的表达水平较后者显著升高(P<0.01);免疫组织化学显示肾透明细胞癌组织中,AnnexinⅡ的阳性表达率高达67.5%,与癌旁组织存在明显差异(P<0.01);AnnexinⅡ在肾透明细胞癌组织中以胞膜表达为主,其表达状况与肾透明细胞癌患者的临床分期(P<0.05),组织学分级(P<0.05),肾被膜受侵(P<0.01)和远地转移(P<0.01)紧密相关;并且AnnexinⅡ的表达状况与肾透明细胞癌患者的5年生存率显著相关。结论:AnnexinⅡ在肾透明细胞癌组织中过表达,其与肾癌的发展密切相关,在肾癌的侵袭及转移过程中可能发挥重要作用。 AIM: To discuss the difference of annexin II expression between the Clear-Cell Renal Cell Carcinoma (ccRCC) and the corresponding normal renal tissues, and to reveal the clinical significance of Annexin II expression in ccRCC. METHODS: Western blotting was used to detect the expression of Annexin II in 29 samples of fresh ccRCC and the corresponding normal renal tissues. Annexin II expression was examined in 120 samples of paraffin-embed- ding ccRCC and the corresponding normal renal tissues using immunohistochemistry. Correlations with Annexin II expression and clinic-pathological parameters were analyzed. RESULTS: There was expression of Annexin II in both ccRCC and the corresponding normal renal tissues. In ccRCC tissues, the total levels of Annexin II proteins were significantly higher than that in the corresponding normal renal tissues ( P 〈 0.01). The positive rate of Annexin II expression in immunohistochemistry was 67.5% in the ccRCC tissues, existing significant difference compared with the corresponding normal renal tissues ( P 〈 0.01 ). Expression of Annexin II in ccRCC mainly showed membranous staining. Annexin II expression level was positively correlated with TNM stage ( P 〈 0.05 ), histology grade ( P 〈 0.05), renal capsule infiltration ( P 〈 0.0] ) and distant metastasis (P〈 0.01) of ccRCC. Moreover, Annexin II expression level was significantly correlated with ccRCC patients' 5- years survival rate ( P 〈 0.01 ). CONCLUSION. Overexpression of Annexin II in the ccRCC is closely correlated with the ccRCC development. It may play an important role in the process of ccRCC invasion and metastasis.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2012年第1期59-62,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金资助项目(18110049)
关键词 AnnexinⅡ 转移潜能 透明细胞癌 肾癌 Annexin II metastatic potential clear-cell car-cinoma renal cell cancer
  • 相关文献

参考文献15

  • 1Motzer R J, Hutson TE, Tomczak P, et al. Overall survival and update results for sunitinib compared with interferon Alfa in patients with renal cell carcinoma[ J]. J Clin Oncol, 2009, 27 (22) : 3584 -3590.
  • 2Rini BI, Halabi S, Rosenberg J, et al. Bevacizumab plus interferon-α versus interfereon-α monotherapy in patients with metastatic renal cell carcinoma: Results of overall survival for CALGB90206 [ J ]. J Clin Oncol(Meeting Abstracts) 2009, 27(15S) : 5019.
  • 3I Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics[J]. Oncogene, 2010, 29(5) : 625 -634.
  • 4Linehan WM, Srinivasan R, Schmidt LS. The genetic basis of kidney cancer: a metabolic disease[J]. Nat Rev Urol, 2010, 7(5) : 277 -285.
  • 5李旭,南勋义,党建功,陈葳,杨玉琮,阎春芳.人肾癌细胞系RLC-310的建立和生物学特性[J].中华泌尿外科杂志,1996,17(11):643-646. 被引量:2
  • 6Yang J, Li A, Yang Y, et al. Identification of cyclophilin A as a po- tential prognostic factor for clear-cell renal cell carcinoma by compara- tive proteomic analysis[ J ]. Cancer Biology Therapy, 2011, 11 (5) : 535 - 546.
  • 7薛雷喜,江淼,阮长耿.Annexin A2的生理特性和生物学功能[J].江苏医药,2010,36(9):1081-1083. 被引量:8
  • 8李鹏鸽,杨艳丽,葛玉婷,尹田乐,侯颖春.膜联蛋白A2在肿瘤生长调节与细胞骨架活动中的作用[J].生理科学进展,2010,41(6):457-460. 被引量:11
  • 9Unwin RD, Craven RA, Harnden P, et al. Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mito- chondrial aspects of the Warburg effect [ J ]. Proteomics, 2003, 3 (8) : 1620-1632.
  • 10Zimmermann U, Woenckhaus C, Pietschmann S, et al. Expression of Annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome[ J]. Virchows Arch, 2004, 445 (4) : 368 -374.

二级参考文献35

  • 1黄昀,傅松滨.AnnexinⅡ的遗传学研究[J].国外医学(遗传学分册),2004,27(6):330-333. 被引量:3
  • 2Hajjar KA, Krishnan S. Annexin II: a mediator of the plas min/plasminogen activator system[J]. Trends Cardiovasc Med, 1999,9(5) : 128- 138.
  • 3Hastie C, Masters JR, Moss SE, et al. Interferon-γ reduces cell surface expression of annexin 2 and suppresses the inva sire capacity of prostate cancer cells[J].The Journal of Biological Chemistry, 2008,283 (18) : 12595-12603.
  • 4Deora AB,Kreitzer G,Jacovina AT, et al. An annexin 2 phosphorylation switch mediates pll-dependent translocation of annexin 2 to the cell surface[J]. The Journal of Biological Chemistry, 2004,279(42) : 43411-43418.
  • 5Lei HT, Romeo G, Kazlauskas A. Heat shock protein 90 α-dependent translocation of annexinII to the surface of endothelial cells modulates plasmin activity in the diabetic rat aorta[J]. Cire Res, 2004,94(7) : 902- 909.
  • 6Patchell BJ, Wojcik KR, Yang TL, et al. Glycosylation and annexin II cell surface translocation mediate airway epithelial wound repair[J]. Am J Physiol Lung Cell Mol Physiol, 2007, 293(2):354-363.
  • 7Tsunezumi J, Yamamoto K, Higashi S, et al. Matrilysin (matrix metalloprotease-7) cleaves membrane-bound annexin II and enhances binding of tissue-type plasminogen activator to cancer cell surfaces[J]. FEBS Journal, 2008, 275 (19): 4810-4823.
  • 8Senell JS,Cesarman GM,Jacovina AT,et al. Annexin II and bleeding in acute promyelocytic leukemia[J]. N Engl J Med, 1999,340(13) :994-1004.
  • 9Madoiwa S, Someya T, Hironaka M, et al. Annexin 2 and hemorrhagic disorder in vascular intimal carcinomatosis[J]. Thromb Res, 2007,119(2) : 229-240.
  • 10Derry MC, Sutherland MR, Restall CM, et al. Annexin 2- mediated enhancement of cytomegalovirus infection opposes inhibition by annexin 1 or annexin 5[J]. Journal of General Virology, 2007,88(1) : 19-27.

共引文献16

同被引文献61

  • 1刘颖,凌世淦,于继云.肾癌相关基因的研究进展[J].细胞与分子免疫学杂志,2005,21(B03):110-112. 被引量:6
  • 2Yang J, Li A, Yang Y, et al. Identification of cyclophilin A as a poten- tial prognostic factor for clear-cen renal cell carcinoma by comparative proteomic analysis[J]. Cancer Biol Ther, 2011, 11(5) : 535 -546.
  • 3Skinnider BF, Amin MB. An immunohistochemical approach to thedifferential diagnosis of renal tumors[ J]. Semin Diagn Pathol, 2005, 22(1) : 51 -68.
  • 4Sarto C, Frutiger S, Cappellano F, et al. Modified expression of plasma glutathione peroxidase and manganese superoxide dismutase in human renal cell carcinoma [ J ]. Electrophoresis, 1999, 20 ( 17 ) : 3458 - 3466.
  • 5Wang X, Phelan SA, Forsroan-Semb K, et al. Mice with targeted mu- tation of peroxiredoxin 6 develop normally but are susceptible to oxida- tive stress[J]. J Biol Chem, 2003, 278(27) : 25179 -25190.
  • 6Wang Y, Phelan SA, Manevich Y, et al. Transgenic mice overex- pressing peroxiredoxin 6 show increased resistance to lung injury in hyperoxia[ J ]. Am J Respir Cell Mol Biol, 2006, 34 (4) : 481 - 486.
  • 7Wang Y, Feinstein SI, Manevich Y, et al. Peroxiredoxin 6 gene- targeted mice show increased lung injury with paraquat-induced oxida- tive stress [ J ]. Antioxid Redox Signal, 2006, 8 ( 1-2 ) : 229 - 237.
  • 8Kim JH, Bogner PN, Baek SH, et al. Up-regulation of peroxiredoxin 1 in lung cancer and its implication as a prognostic and therapeutictar- get[J]. Clin Cancer Res, 2008, 14(8) : 2326 -2333.
  • 9Chung KH, Lee DH, Kim Y, et al. Proteomic identification of over- expressed PRDX 1 and its clinical implications in ovarian carcinoma [J]. J Proteome Res, 2010, 9(1) : 451 -457.
  • 10Yanagawa T, Omura K, Harada H, et al. Peroxiredoxin I expression in tongue squamous cell carcinomas as involved in tumor recurrence [J]. Int J Oral Maxillofac Surg, 2005, 34(8) : 915 -920.

引证文献7

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部